Napolitano Janet

SEC Form 4 insider trading activity

Napolitano Janet has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including FTNT, VIR, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.

On the most recent filing, Napolitano Janet is listed as Director at Vir Biotechnology, Inc. Inside the rolling window, Napolitano Janet reported no open-market purchases and 1 open-market sale totaling $30K in VIR.

Companies traded

Other insiders at FTNT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$30K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
VIR
Napolitano Janet
Sale$30KJun 2SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Napolitano Janet made?

Napolitano Janet has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including FTNT, VIR since 2025.

Which companies does Napolitano Janet trade?

Napolitano Janet has filed SEC Form 4 disclosures for 2 companies, including FTNT, VIR.

When was Napolitano Janet's most recent SEC Form 4 filing?

Napolitano Janet's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.

What is Napolitano Janet's total buy and sell value in the current window?

Inside the rolling retention window, Napolitano Janet bought $0 and sold $30K based on SEC Form 4 filings.

What was Napolitano Janet's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 3,200 VIR shares on 2026-06-01, worth $30K, per SEC Form 4 filings.